Decades of reliance on the antibiotic rifampicin have fueled the rise of drug-resistant Mycobacterium tuberculosis (Mtb). But ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new ...

A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly ...

Across Europe, tuberculosis (TB) is once again raising alarm, particularly the extensively drug-resistant form (XDR-TB), which is proving as deadly as before antibiotics were discovered. A large ...

One in five cases of tuberculosis in the European region goes undiagnosed as drug resistance remains higher than in other parts of the world, a new report by the World Health Organization (WHO) and ...

When the antibiotic bedaquiline was introduced in 2012, it was the first new tuberculosis drug in over 40 years. Bedaquiline quickly became the key drug in all standard drug-resistant tuberculosis ...

Scientists have developed an artificial intelligence-based method to more accurately detect antibiotic resistance in deadly bacteria such as tuberculosis and staph. The breakthrough could lead to ...

Researchers have discovered a new antibiotic in the lungs of a cystic fibrosis patient that may prove effective in the fight against antibiotic-resistant tuberculosis, according to a study published ...

Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...

Modified antibiotics beat a stubborn lung pathogen and dodge metabolic landmines, offering new hope for patients with HIV, cystic fibrosis, and TB co-infections. Study: Next-generation rifamycins for ...